Preview

Head and Neck Tumors (HNT)

Advanced search
Fullscreen

For citations:


Mudunov A.M., Khabazov A.M., Pak M.B., Berelavichus S.V., Chen H. mTOR inhibitor as off-label option in treatment of progressive refractory nasopharyngeal carcinoma. Head and Neck Tumors (HNT). 2025;15(3):124-130. https://doi.org/10.17650/2222-1468-2025-15-3-124-130

Views PDF (Rus): 2
Views PDF (Eng): 16


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2222-1468 (Print)
ISSN 2411-4634 (Online)